- Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A randomized first-in-human, Phase 1, single-center, observer-blind, active-controlled 3-arm study to evaluate the safety, tolerability, and immunogenicity of one single administration of TETRALITE, a novel adjuvanted influenza vaccine, in healthy participants aged 18 to 50 years
This study is testing a new flu vaccine called TETRALITE in healthy adults. Researchers want to see if it's safe, how well people tolerate it, and how strongly it helps the body fight off the flu compared to an existing flu vaccine.
For: InfluenzaBelgium - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2a randomized, observer-blind, study to evaluate the immunogenicity and safety of mRNA-based multivalent seasonal influenza vaccine candidates in adults 18 years of age and older.
This study is testing new flu vaccines for adults aged 18 and over. It aims to see how well these new vaccines help your body fight the flu and if they are safe to use. We want to find out if they cause any side effects.
For: Influenza · HumanBelgium - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2, randomized, dose-finding/dose-confirmation study to evaluate the reactogenicity, safety and immunogenicity of mRNA-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults
This study is testing new mRNA flu vaccines in healthy adults. Researchers want to see how safe they are, if they cause side effects, and how well they help your body fight the flu, compared to existing flu jabs. It's a key first step for new vaccine development.
For: Healthy volunteers (prevention of influenza infection)Belgium